Cardinal Health, Inc.

New York Stock Exchange
Back to all articles
Somewhat Bullish +35

Cardinal Health, Inc. (NYSE:CAH) Receives Average Rating of "Moderate ...

AI-generated analysis

📊 Cardinal Health holds an average 'Moderate Buy' rating from eighteen brokerages with a consensus one-year price target of $251.73.

📈 The company reported Q4 EPS of $3.17, beating analyst estimates by $0.38 on revenue of $60.94 billion.

📉 Revenue missed the specific consensus estimate of $62.10 billion despite an 11% year-over-year growth rate.

💰 Cardinal Health raised its quarterly dividend to $0.5158, offering a 0.9% yield and a 31.50% payout ratio.

🏦 Wellington Management Group increased its stake by 153.2%, now holding shares valued at over $911 million.

📉 Wells Fargo and Evercore recently lowered their price targets to $245 and $240 respectively, though maintaining positive ratings.

🏛️ Norges Bank acquired a new stake in the fourth quarter valued at approximately $790 million.

🔮 The company has set FY 2026 EPS guidance between $10.70 and $10.80, slightly below analyst expectations of $10.77.

Bullish Signals
  • Cardinal Health beat earnings per share estimates by $0.38 in the latest quarter, reporting $3.17 EPS.
  • The company achieved an 11.0% year-over-year revenue increase to reach $60.94 billion during the quarter.
  • TD Cowen lifted its price target to $275 and upgraded the rating to 'buy' in a recent report.
  • Wellington Management Group significantly increased its position by 153.2% in the third quarter.
  • Marshall Wace LLP boosted its stake by over 1,300% in the fourth quarter, adding nearly $196 million to holdings.
  • Norges Bank acquired a substantial new stake valued at approximately $790 million in the fourth quarter.
  • Vanguard Group Inc. increased its holdings by 2.0% in the fourth quarter, maintaining a large position worth over $6.4 billion.
Risk Factors
  • Cardinal Health's revenue of $60.94 billion missed the specific consensus estimate of $62.10 billion.
  • The company reported a negative return on equity of -92.61% for the quarter.
  • Wells Fargo and Evercore recently reduced their price targets to $245 and $240 respectively.
Full Analysis
Shares of Cardinal Health, Inc. (NYSE:CAH) have received an average recommendation of 'Moderate Buy' from eighteen brokerages covering the firm, with fifteen analysts rating it a buy and three holding. The consensus one-year price target stands at $251.73. Recent analyst actions include TD Cowen lifting its price target to $275 with a 'buy' rating in July, while Wells Fargo and Evercore recently lowered their targets to $245 and $240 respectively, maintaining positive 'overweight' and 'outperform' ratings. Cardinal Health reported fourth-quarter earnings on April 30th, delivering $3.17 EPS which significantly beat the consensus estimate of $2.79 by $0.38. Revenue reached $60.94 billion, representing an 11.0% year-over-year increase, though it missed the specific revenue consensus of $62.10 billion. The company has set full-year 2026 guidance between $10.70 and $10.80 EPS, slightly below analyst expectations of $10.77. The company recently increased its quarterly dividend to $0.5158 per share, paid on July 15th with an ex-dividend date of July 1st, resulting in a 0.9% yield and a 31.50% payout ratio. Significant institutional activity includes Wellington Management Group raising its position by 153.2%, Marshall Wace LLP increasing holdings by over 1,300%, and Norges Bank acquiring a stake valued at approximately $790 million in the fourth quarter.